Shotwise
Take control of your GLP-1 treatment journey with Shotwise, the ultimate companion app designed to simplify injection tracking and monitor your progress effortlessly.
The problem it says it solves
Simplifies injection tracking and monitoring of GLP-1 treatment progress.
Who it says it is for
Individuals undergoing GLP-1 treatment for weight loss
Revenue as published
Figures below come from RevenueCat, connected by the company itself, and were read on 6 November 2026.
| Figure | Value | What it means |
|---|---|---|
| Revenue, last 30 days | 609 | USD received in the thirty days before the snapshot |
| Revenue, trailing 12 months | 15,538 | USD received in the twelve months before the snapshot |
| Monthly recurring revenue | 956 | The recurring part only, as the provider reports it |
| Active subscriptions | 655 | Count of live subscriptions |
Listed for sale
Asking 35,000 USD, stated at a multiple of 4.8x, with 8 offers received. The price is stated by the seller on the source profile, it is not verified and it is not an offer made by this site.
Profile
| Audience | B2C |
| Payment provider | RevenueCat |
| Pricing | 4.99/week, 9.99/month, 24.99/year |
Markets Health & Fitness Mobile Apps.